ALC(ALC)
ALC
Signal
Leaning Bullish1↑
PRICE
Prev Close
64.00
Open
64.53
Day Range63.60 – 64.98
63.60
64.98
52W Range61.84 – 92.55
61.84
92.55
6% of range
VOLUME & SIZE
Avg Volume
1.8M
FUNDAMENTALS
P/E Ratio
38.1x
EPS (TTM)
—
Div Yield
0.00%
Beta
0.87
Market-like
Performance
1D
-0.56%5D↑
+1.48%1M
-20.00%3M
-21.16%6M
-18.04%YTD
-19.25%1Y↓
-29.16%Best: 5D (+1.48%)Worst: 1Y (-29.16%)
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +7% YoY · 55% gross marginValuation
EXPENSIVE
P/E 38x vs ~20x sectorHealth
STRONG
CR 2.2 · FCF $3.50/shBullish
Key MetricsTTM
Market Cap$31.02B
Revenue TTM$10.58B
Net Income TTM$815.33M
Free Cash Flow$1.70B
Gross Margin54.9%
Net Margin7.7%
Operating Margin12.3%
Return on Equity3.7%
Return on Assets2.6%
Debt / Equity0.24
Current Ratio2.20
EPS TTM$1.67
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
3 strong3 concern
48/100Liquidity
2.20Strong
Leverage
0.24Strong
Coverage
8.5xStrong
ROE
3.7%Concern
ROIC
3.7%Concern
Cash
$1.5BConcern
ANALYST COVERAGE25 analysts
HOLD
▲ +22.6%upside to target
L $70.00
Med $78.00consensus
H $97.00Stock Health
Composite Score
2 of 5 signals bullish
5/10
Technicals
●
~RSI RangeRSI 27 — Oversold, watch for bounce
Volume
●
✗Volume FlowDistribution — institutional selling
Fundamentals
●
✓Last EarningsBeat estimates
●
~Analyst ConsensusHold
●
✓LiquidityCurrent Ratio 2.20 — healthy liquidity
Upcoming Events
EEarnings ReportMay 18, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 89 days
PDividend PaymentAug 17, 2026
In 92 days
FinancialsFull statements →
Technicals
Technical SetupBEARISH
Technicals →Trend
▼ DowntrendDeath Cross · 50D trails 200D by 4.1%
-15.3% vs SMA 50 · -18.8% vs SMA 200
Momentum
RSI27.0Oversold — potential bounce
MACD-3.77Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$92.55+45.4%
EMA 200
$78.62+23.5%
EMA 50
$73.73+15.9%
Current
$63.64
52W Low
$61.84-2.8%
52-Week RangeNear 52-week low
$61.846th %ile$92.55
Squeeze SetupVolume-based
Distribution PressureHeavy distribution on elevated volume — institutions appear to be exiting. Squeeze setups unlikely while selling pressure persists.
20-Day Money Flow
Acc days:3
Dist days:8
Edge:+5 dist
Volume Context
Avg Vol (50D)1.8M
Recent Vol (5D)
2.2M+26%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 17 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $10.3B $10.3B–$10.3B | — | $3.06 | — | ±1% | High17 |
FY2026(current) | $11.0B $11.0B–$11.0B | ▲ +7.4% | $3.44 | ▲ +12.2% | ±7% | High17 |
FY2027 | $11.7B $11.6B–$11.8B | ▲ +6.1% | $3.92 | ▲ +14.2% | ±3% | High17 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryALC
Last 8Q
+3.3%avg beat
Beat 5 of 8 quartersMissed 2↑ Estimates rising—
Q3'24
+13%
Q4'24
+3%
Q1'25
-4%
Q2'25
+7%
Q3'25
+3%
Q4'25
-1%
Q1'26
+6%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →Neutral — mixed activity
90d▲ 1▼ 0
Wells FargoOverweight
Feb 26
UPGRADE
Deutsche BankBuy
Jan 20
UPGRADE
HSBCHold
Mar 25
DOWNGRADE
RBC CapitalOutperform
Sep 10
UPGRADE
OppenheimerOutperform
May 15
UPGRADE
Piper SandlerOutperform
May 10
UPGRADE
Societe GeneraleSell → Hold
Mar 1
UPGRADE
Societe GeneraleSell
Nov 17
DOWNGRADE
StephensEqual-Weight → Overweight
May 12
UPGRADE
StephensEqual-Weight
Jan 23
DOWNGRADE
Financials
Dividends0.56% yield
+178.2% avg annual growthAnnual Yield0.56%
Annual Div.$0.3593
Est. Annual / Share$0.36
FrequencyAnnual
Q2'21
Q2'22
Q2'23
Q2'24
Q2'25
Q2'26
Dividend per payment — last 6 periods
INSTITUTIONAL OWNERSHIP
1
Bank of New York Mellon Corp
15.7M▲2
FMR LLC
12.4M▲3
Aristotle Capital Management, LLC
9.7M▼4
AKO CAPITAL LLP
9.3M▲5
Zurcher Kantonalbank (Zurich Cantonalbank)
8.0M▲6
UBS Group AG
5.9M▼7
GOLDMAN SACHS GROUP INC
5.8M▲8
Select Equity Group, L.P.
5.7M▼News & Activity
ALC News
About
Alcon is an American Swiss medical company specializing in eye care products with headquarters in Geneva, Switzerland, and incorporated in Fribourg, Switzerland.
Royce R. BedwardSenior Vice President, General Counsel & Corporate Secretary
Timothy C. StonesiferSenior Vice President & Chief Financial Officer
Ian BellSenior Vice President & Chief Operating Officer
Peers— —(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
ALC◀ | $63.64 | -0.56% | $31.0B | 38.0 | +494.4% | 942.2% | 1500 |
| $404.35 | -3.20% | $2.1T | 30.5 | +3296.8% | 4510.0% | 1500 | |
| $132.58 | -6.05% | $307.9B | 20.7 | -44.8% | 1012.0% | 1500 | |
| $88.38 | -2.58% | $303.7B | 13.6 | +318.8% | 1510.7% | 1500 | |
| $148.08 | -1.13% | $282.6B | 21.0 | +597.3% | 2564.4% | 1500 | |
| $181.58 | -1.83% | $281.6B | 26.9 | +862.9% | 1745.9% | 1500 | |
| $183.40 | -0.23% | $256.1B | 16.8 | +213.3% | 1482.4% | 1500 | |
| Sector avg | — | -2.23% | — | 23.9 | +819.8% | 1966.8% | 1500 |